Blockade of the metabotropic glutamate (mGluR2) modulates arousal through vigilance states transitions: Evidence from sleep-wake EEG in rodents

Behavioural Brain Research

Volumn 270, Issue , 2014, Pages 56-67

  Ahnaou, A ^a   Ver Donck, L ^a   Drinkenburg, W H I M ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Arousal behavior; MGluR2; Psychiatric disorders; Rodents; States transition; Theta gamma oscillations

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 4 [3 (2,6 DIMETHYLPYRIDIN 4 YL)PENYL] 7 METHYL 8 TRIFLUOROMETHYL 1,3 DIHYDROBENZO[B][1,4]DIAZEPIN 2 ONE; AMINO ACID RECEPTOR AFFECTING AGENT; AMPHETAMINE; METABOTROPIC RECEPTOR 2; UNCLASSIFIED DRUG; AMINO ACID; AMINO ACID RECEPTOR BLOCKING AGENT; METABOTROPIC RECEPTOR; XANTHENE DERIVATIVE;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; BODY TEMPERATURE; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY PHASE SYNCHRONIZATION; GAMMA RHYTHM; HOMEOSTASIS; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; RODENT; SLEEP WAKING CYCLE; SOMNOLENCE; THETA RHYTHM; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; GENETICS; KNOCKOUT MOUSE; PHYSIOLOGY; SLEEP; SPRAGUE DAWLEY RAT; WAKEFULNESS;

AMINO ACIDS; ANIMALS; AROUSAL; BODY TEMPERATURE; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; LOCOMOTION; MALE; MICE; MICE, KNOCKOUT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SLEEP; WAKEFULNESS; XANTHENES;

EID: 84901327592     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.05.003     Document Type: Article

References (61)

1. Niswender C.M., Conn P.J. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 2010, 50:295-322.
2. Carlson G.C. Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders. Pharmacol Biochem Behav 2012, 100:850-854.
3. Conn P.J., Jones C.K. Promise of mGluR2/3 activators in psychiatry. Neuropsychopharmacology 2009, 34:248-249.
4. Chaki S., Hikishi H. Targeting of metabotropic glutamate receptors for the treatment of schizophrenia. Curr Phar Des 2011, 17:94-102.
5. Harvey B.H., Shahid M. Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models. Pharmacol Biochem Behav 2012, 100:775-800.
6. Linden A.M., Schoepp D.D. Metabotropic glutamate receptor targets for neuropsychiatric disorders. Drug Discov Today 2006, 3:507-517.
7. Krystal J.H., Mathew S.J., D'Souza D.C., Garakani A., Gunduz-Bruce H., Chamey D.S. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 2010, 24:669-693.
8. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression. An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
9. Naylor E., Aillon D.V., Gabbert S., Harmon H., Johnson D.A., Wilson G.S., et al. Simultaneous real-time measurement of EEG/EMG and l-glutamate in mice: a biosensor study of neuronal activity during sleep. J Electroanalytical Chem 2011, 656:106-113.
10. Kodama T., Lai Y.Y., Siegel J.M. Enhanced glutamate release during REM sleep in the rostromedial medulla as measured by in vivo microdialysis. Brain Res 1998, 780:178-181.
11. Lopez-Rodriguez F., Medina-Ceja L., Wilson C.L., Jhung C.L., Morales-Villagram A. Changes in extracellular glutamate levels in rat orbitofrontal cortex during sleep and wakefulness. Arch Med Res 2007, 38:52-55.
12. Ahnaou A., Dautzenberg F.M., Geys H., Imogai H., Gibelin A., Moechars D., et al. Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture. Eur J Pharmacol 2009, 603:62-72.
13. Feinberg I., Schoepp D.D., Hsieh K.C., Darchia N., Campbell I.G. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats. J Pharmacolo Exp Ther 2005, 312:826-833.
14. Fell M.J., Witkin J.M., Falcone J.F., Katner J.S., Perry K.W., Hart J., et al. N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes. J Pharmacol Exp Ther 2011, 336:165-177.
15. Dong E., Wellman L.L., Yang L., Sanford L.D. Effects of microinjections of Group II metabotropic glutamate agents into the amygdala on sleep. Brain Res 2012, 1452:85-95.
16. Parmentier-Batteur S., O'Brien J.A., Doran S., Nguyen S.J., Flick R.B., Uslaner J.M., et al. Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration. Neuropharmacology 2012, 62:1453-1460.
17. Ohishi H., Shigemoto R., Nakanishi S., Mizuno N. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 1993, 53:1009-1018.
18. Gu G., Lorrain D.S., Wei H., Cole R.L., Zhang X., Daggett L.P., et al. Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition. Brain Res 2008, 1197:47-62.
19. Tamaru Y., Nomura S., Mizuno N., Shigemoto R. Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience 2001, 106:481-503.
20. Sanford L.D., Parris B., Tang X. GABAergic regulation of the central nucleus of the amygdala: implications for sleep control. Brain Res 2002, 956:276-284.
21. Hikichi H., Kaku A., Karasawa J., Chaki S. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats. J Pharmacol Sci 2013, 122:10-16.
22. Paterson L.M., Nutt D.J., Wilson S.J. Sleep and its disorders in translational medicine. J Psychopharmacol 2011, 25:1226-1234.
23. Kingston A.E., Ornstein P.L., Wright R.A., Johnson B.G., Mayne N.G., Burnett J.P., et al. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 1998, 37:1-12.
24. Campo B., Kalinichev M., Lambeng N., El Yacoubi M., Royer-Urios I., Schneider M., et al. Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression. J Neurogenet 2011, 25:152-166.
25. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 1997, Academic Press, San Diego, CA. 2nd ed.
26. Jones B.E. Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex. Prog Brain Res 2004, 145:157-169.
27. Saper C.B., Scammell T.E., Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437:1257-1263.
28. Brown R.E., Basheer R., McKenna J.T., Strecker R.E., McCarley R.W. Control of sleep and wakefulness. Physiol Rev 2012, 9:1087-1187.
29. Campbell I.G., Feinberg I. NREM delta stimulation following MK-801 is a response of sleep systems. J Neurophysiol 1996, 76:3714-3720.
30. Datta S., Spoley E.E., Patterson E.H. Microinjection of glutamate into the pedunculopontine tegmentum induces REM sleep and wakefulness in the rat. Am J Physiol Regul Integr Comp Physiol 2001, 280:R752-R759.
31. Kohlmeier K.A., Christensen M.H., Kristensen M.P., Kristiansen U. Pharmacological evidence of functional inhibitory metabotrophic glutamate receptors on mouse arousal-related cholinergic laterodorsal tegmental neurons. Neuropharmacology 2013, 66:99-113.
32. Higgins G.A., Ballard T.M., Kew J.N., Richards J.G., Kemp J.A., Adam G., et al. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 2004, 46:907-917.
33. Buzsaki G. Theta rhythm of navigation: link between path integration and landmark navigation, episodic and semantic memory. Hippocampus 2005, 15:827-840.
34. Colgin L.L. Oscillations and hippocampal-prefrontal synchrony. Curr Opin Neurobiol 2011, 21:467-474.
35. Vertes R.P. Hippocampal theta rhythm: a tag for short-term memory. Hippocampus 2005, 15:923-935.
36. Hasan S., Pradervand S., Ahnaou A., Drinkenburg W., Tafti M., Franken P. How to keep the brain awake? The complex molecular pharmacogenetics of wake promotion. Neuropsychopharmacology 2009, 34:1625-1640.
37. Gruner J.A., Mathiasen J.R., Flood D.G., Gasior M. Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats. J Pharmacol Exp Ther 2011, 337:380-390.
38. Wisor J.P., Dement W.C., Aimone L., Williams M., Bozyczko-Coyne D. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat. Pharmacol Biochem Behav 2006, 85:492-499.
39. Edgar D.M., Seidel W.F. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther 1997, 283:757-769.
40. Lin J.S., Gervasoni D., Hou Y., Vanni-Mercier G., Rambert F., Frydman A., et al. Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat. J Sleep Res 2000, 9:89-96.
41. Karasawa J., Yoshimizu T., Chaki S. A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell. Neurosci Lett 2006, 393:127-130.
42. Mochizuki T., Crocker A., McCormack S., Yanagisawa M., Sakurai T., Scammell T.E. Behavioral state instability in orexin knock-out mice. J Neurosci 2004, 24:6291-6300.
43. Stenberg D., Litonius E., Halldner L., Johansson B., Fredholm B.B., Porkka-Heiskanen T. Sleep and its homeostatic regulation in mice lacking the adenosine A1 receptor. J Sleep Res 2003, 12:283-290.
44. Huang Z.L., Mochizuki T., Qu W.M., Hong Z.Y., Watanabe T., Urade Y., et al. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A 2006, 103:4687-4692.
45. Gleason S.D., Li X., Smith I.A., Ephlin J.D., Wang X.-S., Heinz B.A., et al. mGlu2/3 agonist-induced hyperthermia: an in-vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in mice 2013, 554-566.
46. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7:137-151.
47. Chaki S., Okubo T., Sekiguchi Y. Non-monoamine-based approach for the treatment of depression and anxiety disorders. Recent Pat CNS Drug Discov 2006, 1:1-27.
48. Palucha A., Pilc A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 2007, 115:116-147.
49. Pilc A., Wieronnska J.M., Skolnick P. Glutamate-based antidepressants: preclinical psychopharmacology. Biol Psychiatry 2013, 73:1125-1132.
50. Wright R.A., Arnold M.B., Wheeler W.J., Ornstein P.L., Schoepp D.D. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain. J Pharmacol Exp Ther 2001, 298:453-460.
51. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001, 11:240-249.
52. Panconi E., Roux J., Altenbaumer M., Hampe S., Porsolt R.D. MK-801 and enantiomers: potential antidepressants or false positives in classical screening models?. Pharmacol Biochem Behav 1993, 46:15-20.
53. American Psychiatric Association Task Force on DSM-IV, diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th ed.
54. Peterson M., Benca R. Sleep in mood disorders. Psychiatr Clin N Am 2006, 29:1009-1032.
55. Fava M. Daytime sleepiness and insomnia as correlates of depression. J Clin Psychiatr 2004, 16:27-32.
56. Pillai V., Kalmbach D.A., Ciesla J.A. A meta-analysis of electroencephalographic sleep in depression: evidence for genetic biomarkers. Biol Psychiatry 2011, 70:912-919.
57. Steiger A., Kimura M. Wake and sleep EEG provide biomarkers in depression. J Psychiatr Res 2010, 44:242-252.
58. Ivarsson M., Paterson L.M., Hutson P.H. Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats. Eur J Pharmacol 2005, 22:63-71.
59. Wilson S., Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 2005, 65:927-947.
60. Mann J.J. The medical management of depression. N Engl J Med 2005, 353:1819-1834.
61. Mayers A.G., Baldwin D.S. Antidepressants and their effect on sleep. Hum Psychopharmacol 2005, 20:533-559.